Sage Journals: Discover world-class research

Abstract

Myocardial infarction (MI) is associated with an angiogenic response, critical for healing and cardiac repair. Using a canine model of myocardial ischemia and reperfusion, we examined the structural characteristics of the evolving microvasculature in healing MI. After 7 days of reperfusion, the infarcted territory was rich in capillaries and contained enlarged, pericyte-poor “mother vessels” and endothelial bridges. During scar maturation arteriolar density in the infarct increased, and a higher percentage of microvessels acquired a pericyte coat (60.4 ± 6.94% after 28 days of reperfusion vs 30.17 ± 3.65% after 7 days of reperfusion; p<0.05). The microvascular endothelium in the early stages of healing showed intense CD31/PECAM-1 and CD146/Mel-CAM immunoreactivity but weak staining with the Griffonia simplicifolia lectin I (GS-I). In contrast, after 28 days of reperfusion, most infarct microvessels demonstrated significant lectin binding. Our findings suggest that the infarct microvasculature undergoes a transition from an early phase of intense angiogenic activity to a maturation stage associated with pericyte recruitment and formation of a muscular coat. In addition, in the endothelium of infarct microvessels CD31 and CD146 expression appears to precede that of the specific sugar groups that bind the GS-I lectin. Understanding of the mechanisms underlying the formation and remodeling of the microvasculature after MI may be important in designing therapeutic interventions to optimize cardiac repair.

Keywords

myocardial infarction lectin CD31 CD146 endothelium angiogenesis pericyte α-smooth muscle actin healing

Angiogenesis follows a well-orchestrated sequence of events leading to a phase of vascular maturation and remodeling (Carmeliet and Collen 1997; Folkman 1997; Brown et al. 1998; Carmeliet 2000; Carmeliet and Jain 2000; Liekens et al. 2001). Angiogenic endothelial cells demonstrate phenotypic characteristics distinctly different from those of resting quiescent endothelial cells. Sprouting neovessels have been shown to express the integrins αvβ3 (Brooks et al. 1994; Clark et al. 1996) and αvβ5 (Friedlander et al. 1996), the cell surface glycoprotein Thy-1 (Lee et al. 1998), and the VEGF receptor flk-1/kDR (Millauer et al. 1993), whereas proliferating endothelial cells demonstrate increased expression of adhesion molecules such as E-selectin (Bischoff et al. 1997). Neovessel formation is followed by acquisition of a pericyte coat, which appears to influence the maturation and remodeling of microvessels (Benjamin et al. 1998; Hellstrom et al. 2001; Lafleur et al. 2001). Pericyte coating may mark the end of a “plasticity window,” during which the microvasculature is most responsive to changes in the physiological needs of the tissue, and may ensure neovessel survival.

Effective wound healing is dependent on the formation of a microvascular network capable of supplying the healing infarct with oxygen and nutrients (Tonnesen et al. 2000). Myocardial infarction (MI) is associated with release of angiogenic factors (Li et al. 1996; Lee et al. 2000), which may be critical for neovessel formation in the healing area. In this study we examined the morphological characteristics of the microvasculature in reperfused canine MI. We demonstrated the presence of enlarged pericyte-poor vascular structures in the early stages of healing and noted an increased percentage of pericyte-coated microvessels and a higher arteriolar density during scar maturation. In addition, we found that infarct endothelial cells in the early phase of healing show intense staining for CD31/PECAM-1 and CD146/MEL-CAM but weak Griffonia simplicifolia-I lectin staining, suggesting that PECAM-1 and MEL-CAM expression may precede that of the specific sugar groups that bind the GS-I lectin in the neovessels of healing MI.

Materials and Methods

Ischemia/reperfusion Protocols

Healthy mongrel dogs (15–25 kg) of either sex were surgically instrumented as previously described (Frangogiannis et al. 1998a; 2000a). Anesthesia was induced IV with 10 mg/kg methoexital sodium (Brevital; Eli Lilly, Indianapolis, IN) and maintained with the inhalation anesthetic isoflurane (Anaquest; Madison, WI). A midline thoracotomy provided access to the heart and mediastinum. Subsequently, a hydraulically activated occluding device and a Doppler flow probe were secured around the circumflex coronary artery just proximal or just distal to the first branch. Choice of location depended on the proximity and anatomic arrangement. Indwelling catheters placed in the right atrium, left atrium, and femoral artery allowed blood sampling and pressure monitoring as needed. After surgery, the animals were allowed to recover for 72 hr before occlusion. Coronary artery occlusion was achieved by inflating the coronary cuff occluder until mean flow in the coronary vessel was zero, as determined by the Doppler flow probe. At the end of 1 hr, the cuff was deflated and the myocardium was reperfused. Reperfusion intervals ranged from 7 to 28 days. Circumflex blood flow arterial blood pressure, heart rate, and ECG (standard limb II) were recorded continuously. Analgesia was accomplished with IV pentazocine (Talwin; Winthrop Pharmaceuticals, New York, NY) 0.1–0.2 mg/kg. After the reperfusion periods, hearts were stopped by rapid IV infusion of 30 mEq of KCl and removed from the chest for sectioning from apex to base into four transverse rings ~1 cm in thickness. The posterior papillary muscle and the posterior free wall were identified. Tissue samples were isolated from infarcted or normally perfused myocardium based on visual inspection. Myocardial segments were fixed in B^∗5 fixative (Beckstead 1994) for histological analysis. Duplicate adjacent samples were also processed for blood flow determinations using radiolabeled microspheres as previously described (Frangogiannis et al. 1998b). Animals included in the study underwent 7 days (n = 4), 14 days (n = 3), or 28 days of reperfusion (n = 3) and demonstrated evidence of MI based on light microscopic examination of hematoxylin-eosin-stained tissue for replacement fibrosis. Samples described as ischemic were all from areas where ischemic blood flow was less than 25%. Samples of control tissues were taken from the anterior septum and had normal blood flow during coronary occlusion.

Immunohistochemistry

For histological study of cardiac tissue, sections taken from endocardium to epicardium were fixed in B^∗5 fixative and embedded in paraffin. Sequential 3–5 μm sections were cut by microtomy. Immunostaining was performed using the ELITE mouse kit (Vector Laboratories; Burlingame CA) as previously described (Frangogiannis et al. 1999, 2000b). Briefly, sections were pretreated with 3% hydrogen peroxide to inhibit endogenous peroxidase activity and incubated with 2% horse serum to block nonspecific protein binding. Subsequently, they were incubated with the primary antibody for 2 hours at room temperature. After rinsing with PBS, the slides were incubated for 30 min with the secondary antibody. The slides were rinsed with PBS and incubated for 30 min in ABC reagent (Hsu et al. 1981). Peroxidase activity was detected using diaminobenzidine (DAB) with nickel (Vector). Slides were counterstained with eosin.

The following primary monoclonal antibodies were used for immunohistochemistry: anti-CD31 monoclonal antibody (Frangogiannis et al. 2000c) (Dako; Carpinteria CA) to label endothelial cells, anti-α-smooth muscle actin antibody (Frangogiannis et al. 1998c) (Sigma; St Louis MO), and the anti-CD146 monoclonal antibody (St Croix et al. 2000) (Chemicon; Temecula CA). Sections incubated with nonimmune serum were used as negative controls. Dual immunohistochemistry was performed using peroxidase-based staining for CD31 followed by alkaline phosphatase-based staining for α-smooth muscle actin developed with the alkaline phosphatase substrate kit I (Vector). Dual stained slides were coverslipped without counterstaining.

Lectin Histochemistry

Lectin histochemistry was performed to identify endothelial cells using the Griffonia simplicifolia lectin I (GS-I) as previously described (Orgad et al. 1984; Alroy et al. 1987). Briefly, sections were pretreated with 3% hydrogen peroxide to inhibit endogenous peroxidase activity and incubated with 2% horse serum. Subsequently they were incubated with biotinylated Griffonia (Bandeiraea) simplicifolia lectin I (Vector) (20 μg/ml with 10 mM HEPES, pH 7.5, 0.15 M NaCl) for 30 min at room temperature. After rinsing with PBS the slides were incubated for 30 min with ABC reagent. Peroxidase activity was detected using DAB with nickel. Slides were counterstained with eosin.

Quantitative Analysis and Statistics

At least two ischemic and two control samples were studied from each experiment. Sections stained using dual immunohistochemistry combining peroxidase-based labeling for CD31 with alkaline phosphatase-based staining for α-smooth muscle actin were photographed with a Leaf MicroLumina digital camera (resolution 300 dpi) mounted on a Zeiss Axioskop microscope. Ten different fields from each control and ischemic sample were analyzed. The percentage of microvessels coated with an α-smooth muscle actin-positive pericyte coat was calculated in the healing infarcts after 7, 14, and 28 days of reperfusion. In addition, the number of arterioles (microvessels fully coated with a muscular coat and with a minor axis >15 μm) was counted in control and fibrotic areas, and expressed as arterioles/mm² (arteriolar density). Statistical analysis was performed using ANOVA followed by t-test corrected for multiple comparisons (Student-Newman-Keuls). Significance was set at p<0.05.

Results

Morphological Characteristics of Infarct Microvessels

Immunohistochemical staining for CD31 identified the vascular endothelium in control canine myocardium and in the healing MIs. The infarcted territory was highly vascular after 7–14 days of reperfusion (Figure 1A). Infarct microvessels were predominantly capillaries, however the presence of enlarged, pericyte-poor “mother vessels” (Paku and Paweletz 1991; Pettersson et al. 2000) was noted (Figure 1C). In addition, endothelial bridges (Figure 1D) dividing the vascular lumen into multiple smaller channels were occasionally seen. After 28 days of reperfusion the scar contained regions of low vascularity (Figure 1B). This is consistent with our previous findings showing decreasing microvascular density with scar maturation (Frangogiannis et al. 2000c).

Pericyte Coating During Maturation of Myocardial Scars

Staining for α-smooth muscle actin identified myofibroblasts and pericytes in the control myocardium and in the healing infarcts. In control areas, α-smooth muscle actin staining was almost exclusively localized in the arteriolar media (Figure 2A). Using dual immunohistochemical staining, we found that in the control canine myocardium less than 1% of the capillaries had an α-smooth muscle actin-positive pericyte coat (Figure 2A).

Figure 1

(A) Immunohistochemical staining with an antibody to CD31 in an infarcted area after 1 hr of ischemia and 7 days of reperfusion. The scar is highly vascular demonstrating a large number of capillaries. (B) CD31 immunostaining in a mature scar (1 hr ischemia/28 days reperfusion) demonstrating an area of fibrosis with low vascularity. (C) Dual immunohistochemical staining combining peroxidase-based immunohistochemistry for CD31 (black) and alkaline phosphatase immunostaining for α-smooth muscle actin (red) in a canine infarct after 1 hr of ischemia and 7 days of reperfusion. A large, dilated pericyte-poor vessel (“mother vessel”) is noted (arrow). (D) CD31 Immunohistochemistry in a canine infarct (1 hr ischemia/7 days reperfusion) demonstrating a vascular structure with endothelial bridges and multiple lumens (arrow). (A, B,D) Counterstained with eosin. Bars = 50 μm.

Figure 2

(A) Dual immunohistochemistry of control canine myocardium combining peroxidase-based staining for CD31 (black) and α-smooth muscle actin immunohistochemistry with an alkaline phosphatase-based method (red). α-Smooth muscle actin immunoreactivity is predominantly localized in the arteriolar media. (B) Dual immunohistochemistry in the infarcted territory after 1 hr of ischemia and 7 days of reperfusion, demonstrating the presence of α-smooth muscle actin-positive myofibroblasts (arrows). The healing infarct shows a large number of capillaries, many of which lack an α-smooth muscle actin-positive pericyte coat. An enlarged pericyte-poor vascular structure is also noted (arrowhead). (C) After 28 days of reperfusion the scar is less vascular, demonstrating a large number of arterioles (arrows). At this stage myofibroblast numbers are decreased in the healing infarct. Bars = 50 μm.

Figure 3

(A) Progressive increase of the percentage of pericyte-coated microvessels in healing MIs. (B) Arteriolar density increased significantly during healing of reperfused infarcts.

Healing infarcts showed α-smooth muscle actin immunoreactivity in myofibroblast-like cells and perivascular cells (Figure 2B) as previously described (Willems et al. 1994; Frangogiannis et al. 2000c). The wound maturation process was associated with a reduced number of myofibroblasts and a higher percentage of microvessels coated with α-smooth muscle ac-tin-positive pericytes (30.17 ± 3.65% in infarcts after 7 days of reperfusion vs 60.4 ± 6.93% in infarcts after 1 hr of ischemia and 28 days of reperfusion; p<0.05) (Figures 2C and 3A). As the percentage of uncoated microvessels decreased, a significant increase in arteriolar density was noted (35.725 ± 14.05 arterioles/mm² in infarcts from the 28-day reperfusion group vs 19.11 ± 4.62 arterioles/mm² in infarcts from the 7-day reperfusion group; p<0.05) (Figure 3B).

Infarct Neovessels Express CD31 and CD146 but Show Weak Staining with GS-I Histochemistry

Serial sections from the canine myocardium were stained for CD31 (PECAM-1), CD146 (Mel-CAM/MUC18), and the GS-I lectin (Figure 4). All three methods were effective in identifying microvessels in control canine myocardium. However, lectin histochemistry gave stronger capillary staining (Figure 4B). In contrast, CD31 staining was much more intense in cardiac arterioles and venules, whereas capillaries showed weaker labeling (Figure 4A). CD146 immunoreactivity was found in endothelial and vascular smooth muscle cells as previously described (Figure 4C). After 1 hr of ischemia and 7 days of reperfusion, the infarct microvessels demonstrated intense staining for CD31 (Figures 5A and 5B) but weak binding with the GS-I lectin (Figures 5C and 5D). CD31 staining was more intense in microvessels of the healing infarct than in control myocardium from the same sections, and this appeared to be the most effective technique in identifying arterioles, venules, and capillaries in the infarcted areas. CD146 immunoreactivity was noted in many microvascular endothelial cells and pericytes of the healing infarct (Figures 5E and 5F). In contrast, after 28 days of reperfusion most of the microvessels in the mature scar showed significant staining for the lectin (Figure 6). These findings suggest that, in MI neovessels, PECAM-1 expression may precede that of the specific sugar groups that bind the GS-I lectin.

Discussion

Wound healing is associated with an angiogenic response, which is critical for scar formation. An increase in hypoxia-inducible factor-1 (HIF-1) is an early response to myocardial ischemia or infarction (Lee et al. 2000) and is followed by induction of VEGF (Dvorak et al. 1995; Cao et al. 1998; Veikkola and Alitalo 1999) in the ischemic areas (Forsythe et al. 1996; Li et al. 1996). In the first few hours after MI, induction of angiostatic factors such as the CXC chemokine interferon γ-inducible protein (IP)-10 is noted and may inhibit neovessel formation until the wound is debrided and a provisional fibrin-based matrix is formed (Frangogiannis et al. 2001). Suppression of IP-10 expression after the first 24 hr of reperfusion presumably allows the active angiogenic phase, during which endothelial cells proliferate (Frangogiannis et al. 1998c) and endothelial progenitor cells infiltrate the healing area (Asahara et al. 1999). We have previously described the dynamic changes in microvessel density during scar formation in reperfused MIs (Frangogiannis et al. 2000c). In addition, Arras and co-workers (1998) have reported, using a porcine model of cardiac microembolization, significant capillary growth during the first 7 days, which decreased after 4 weeks. In this study we examined the structural characteristics of the microvasculature in healing MIs. We found a progressive increase in the percentage of pericyte-coated microvessels and a rise in arteriolar density during cardiac repair. Acquisition of a muscular coat may enhance stability of the vasculature, marking the end of a phase of active angiogenesis and vascular remodeling. We also report that microvessels in canine infarcts showed weak GS-I lectin staining in the early phases of healing, illustrating the phenotypic differences of the vascular endothelium in the healing area. These vessels eventually develop GS-I staining at the late stage of scar formation.

Figure 4

Serial section staining of a control myocardial area for CD31 (A), GS-I lectin (B), and CD146 (C). In control canine myocardium GS-I lectin histochemistry shows intense staining of the microvasculature. CD31 is also a good marker for the microvasculature but stains arterioles (a) and venules (v) more prominently than capillaries. CD146 stains both endothelial and vascular smooth muscle cells. All sections were counterstained with eosin. Bars = 50 μm.

Figure 5

Staining of serial sections of an infarcted area after 1 hr of ischemia and 7 days of reperfusion for CD31 (A, B), GS-I lectin histochemistry (C, D), and CD146 (E, F). Intense staining with CD31 is noted in the scar microvessels, including the dilated venules (arrowheads). GS-I lectin histochemistry shows intense microvascular staining in the areas with preserved myocyte architecture (lower and right part of the section) but weak binding in the infarcted territory (arrowheads). CD146 stains microvessel endothelial and smooth muscle cells but is less effective in identifying the venular endothelium. Counterstained with eosin. Bars = 50 μm.

Figure 6

Staining of sections from a canine infarct after 1 hr of ischemia and 28 days of reperfusion with GS-I lectin (A) and CD31 (B). At this stage the mature scar shows intense microvascular staining with both methods. Counterstained with eosin. Bars = 50 μm.

Structural Properties of the Infarct Microvasculature

Angiogenic microvessels demonstrate significant differences in their architecture compared with normal quiescent vessels. Paku and Paweletz (1991) identified enlarged, dilated “mother vessels” with a fragmented basal lamina in tumor-related angiogenesis. Recently, Pettersson and co-workers (2000) described the properties of the new blood vessels induced by VEGF over-expression in normal rat tissues. They reported the transient formation of enlarged, thin-walled pericyte-poor structures, which later evolved into smaller daughter vessels, disorganized glomeruloid bodies, and medium-sized muscular arteries and veins (Pettersson et al. 2000). Generation of dilated enlarged vessels appears to be a characteristic feature of VEGF-mediated angiogenesis in a variety of models (Rosen-stein et al. 1998; Drake and Little 1999; Pettersson et al. 2000).

Healing MIs contain a large number of capillaries in the early stages of healing (Frangogiannis et al. 2000c). Here we describe enlarged pericyte-poor vessels, resembling the “mother vessels” previously described in other models of angiogenesis. Local expression of VEGF may have an important role in the vascular expansion necessary to form these vascular structures. In addition, the relative absence of pericytes is permissive for the angiogenic process and may provide the microvasculature of the infarct with a plasticity window (Benjamin et al. 1998), necessary in this dynamic phase of healing to accommodate the rapidly changing cell populations and metabolic needs. We also noted the occasional presence of transluminal endothelial projections, resembling bridges dividing the vascular structures into multiple lumens (Figure 1C). Scar maturation was associated with the increasing presence of pericyte-coated vessels (Figures 2B and 3) in the infarcted region. In the early stages of healing (7 days of reperfusion), significant numbers of microvessels without an α-smooth muscle actin-positive pericyte coat were noted. In contrast, maturation of the healing infarct was associated with decreased capillarity (Frangogiannis et al. 2000c) (Figures 1B and 2C), an increased percentage of pericyte-coated microvessels (Figure 3A), and a higher arteriolar density (Figure 3B). Investment of growing microvessels with pericytes appears to be coincident with deposition of basement membrane and the cessation of vessel growth (Crocker et al. 1970). Acquisition of a muscular coat may have an inhibitory or suppressive effect on vessel growth. Endothelial cells and pericytes appear to communicate via the release of growth factors that act in a paracrine fashion to influence vascular cell growth and behavior (Hirschi and D'Amore 1996, 1997; Hirschi et al. 1999).

The dynamic structural changes in the infarct microvasculature may have a significant impact on the repair mechanisms after MI. Mother vessels may evolve into muscular arteries and veins, improving blood supply to the injured myocardium, allowing more effective healing, and decreasing infarct extension and ventricular remodeling. Understanding the mechanisms responsible for the formation and maturation of these vascular structures may lead to effective therapeutic strategies aimed at optimizing cardiac repair.

Endothelial Cells in the Early Healing Phase Express CD31 and CD146 but Do Not Show GS-I Lectin Staining

Lectins are glycoproteins, derived from either plant or animal sources, that bind specific carbohydrate moieties of cell surface glycoproteins (Lis and Sharon 1986). Lectin binding intensities may reflect phenotypic changes in the activated angiogenic endothelium of the infarct. Migrating endothelial cells are distinctly hyperglycosylated and express migration-associated glycoproteins (Augustin-Voss and Pauli 1992). Lectin binding was found to be upregulated in the microvascular endothelial cells of the growing corpus luteum (Augustin et al. 1995). However, in a model of rat cornea freeze injury, wound endothelial cells demonstrated decreased binding with wheat germ agglutinin (WGA) and concanavalinA (ConA) (Gordon and Marchand 1990). Furthermore, in the developing rat heart, microvascular CD31 staining preceded GS-I lectin binding, suggesting that PECAM-1 immunoreactivity may be a useful early marker for endothelial cells (Rongish et al. 1995). Our experiments demonstrated intense staining for CD31 in the microvascular endothelium of reperfused canine MIs, which was much more prominent in infarct neovessels than in the vasculature of the control areas. This may reflect the potential role of CD31/PECAM-1 in vessel growth (DeLisser et al. 1997) and tube formation (Yang et al. 1999). In contrast, GS-I lectin staining was intense in the microvascular endothelium of control myocardial areas but not in infarct microvessels after 7 days of reperfusion. Significant lectin binding was noted in more mature scars after 28 days of reperfusion. These findings suggest that changes in lectin binding may reflect the phenotypic modulation of the infarct microvasculature during wound repair.

Our studies also examined the use of CD146 staining to identify the microvasculature in the canine heart. CD146 is a transmembrane glycoprotein constitutively expressed on endothelial cells (Bardin et al. 1996; Shih 1999), with a potential role in cell adhesion and in the rearrangement of the actin cytoskeleton (Anfosso et al. 2001). Infarct microvessels showed CD146 immunoreactivity in all stages of healing.

Conclusions

Vessel growth and maturation are critical for scar formation and cardiac repair. This process represents an important therapeutic target in our efforts to improve post-infarction cardiac recovery (Heymans et al. 1999; Carmeliet 2000). Infarct microvessels undergo phenotypic changes and, after an initial phase of plasticity associated with intense angiogenic activity to meet the metabolic needs of the cellular scar, pericyte recruitment may mark the creation of a more mature vasculature. Understanding the molecular steps involved in this transition may help us design specific interventions to optimize healing of the infarcted myocardium.

Footnotes

Acknowledgements

Supported by NIH Grant HL-42550, the DeBakey Heart Center, and a grant from the Methodist Hospital Foundation (NGF).

We wish to thank Peggy Jackson, Alida Evans, Alejandro Tumang, Stephanie Butcher, and Kathryn Masterman for outstanding technical assistance and Sharon Malinowski and Connie Mata for editorial assistance with the manuscript.

References

Alroy

Goyal

Skutelsky

(1987)

Lectin histochemistry of mammalian endothelium.

Histochemistry 86:603–607

Anfosso

Bardin

Vivier

Sabatier

Sampol

Dignat-George

(2001)

Outside-in signaling pathway linked to CD146 engagement in human endothelial cells.

J Biol Chem 276:1564–1569

Arras

Strasser

Mohri

Doll

Eckert

Schaper

(1998)

Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine.

Basic Res Cardiol 93:97–107

Asahara

Masuda

Takahashi

Kalka

Pastore

Silver

Kearne

Magner

Isner

(1999)

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

Circ Res 85:221–228

Augustin

Braun

Telemenakis

Modlich

Kuhn

(1995)

Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression.

Am J Pathol 147:339–351

Augustin-Voss

Pauli

(1992)

Migrating endothelial cells are distinctly hyperglycsylated and express specific migration-associated cell surface glycoproteins.

J Cell Biol 119:483–491

Bardin

Frances

Lesaule

Horschowski

George

Sampol

(1996)

Identification of the S-Endo 1 endothelial-associated antigen.

Biochem Biophys Res Commun 218:210–216

Beckstead

(1994)

A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues.

J Histochem Cytochem 42:1127–1134

Benjamin

Hemo

Keshet

(1998)

A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.

Development 125:1591–1598

10.

Bischoff

Brasel

Kraling

Vranovska

(1997)

E-selectin is up-regulated in proliferating endothelial cells in vitro.

Microcirculation 4:279–287

11.

Brooks

Clark

Cheresh

(1994)

Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Science 264:569–571

12.

Brown

Guidi

Tognazzi

Dvorak

(1998)

Vascular permeability factor/vascular endothelial growth factor and vascular stroma formation in neoplasia. Insights from in situ hybridization studies.

J Histochem Cytochem 46:569–575

13.

Cao

Linden

Farnebo

Cao

Eriksson

Kumar

Claesson-Welsh

Alitalo

(1998)

Vascular endothelial growth factor C induces angiogenesis in vivo.

Proc Natl Acad Sci USA 95:14389–14394

14.

Carmeliet

(2000)

Mechanisms of angiogenesis and arteriogenesis.

Nature Med 6:389–395

15.

Carmeliet

Collen

(1997)

Molecular analysis of blood vessel formation and disease.

Am J Physiol 273:H2091–2104

16.

Carmeliet

Jain

(2000)

Angiogenesis in cancer and other diseases.

Nature 407:249–257

17.

Clark

Tonnesen

Gailit

Cheresh

(1996)

Transient functional expression of alphaVbeta 3 on vascular cells during wound repair.

Am J Pathol 148:1407–1421

18.

Crocker

Murad

Geer

(1970)

Role of the pericyte in wound healing. An ultrastructural study.

Exp Mol Pathol 13:51–65

19.

DeLisser

Christofidou-Solomidou

Strieter

Burdick

Robinson

Wexler

Kerr

Garlanda

Merwin

Madri

Albelda

(1997)

Involvement of endothelial PE-CAM-1/CD31 in angiogenesis.

Am J Pathol 151:671–677

20.

Drake

Little

(1999)

VEGF and vascular fusion: implications for normal and pathological vessels.

J Histochem Cytochem 47:1351–1356

21.

Dvorak

Brown

Detmar

Dvorak

(1995)

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

Am J Pathol 146:1029–1039

22.

Folkman

(1997)

Angiogenesis and angiogenesis inhibition: an overview.

EXS 79:1–8

23.

Forsythe

Jiang

Iyer

Agani

Leung

Koos

Semenza

(1996)

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.

Mol Cell Biol 16:4604–4613

24.

Frangogiannis

Burns

Michael

Entman

(1999)

Histochemical and morphological characteristics of canine cardiac mast cells.

Histochem J 31:221–229

25.

Frangogiannis

Lindsey

Michael

Youker

Bressler

Mendoza

Spengler

Smith

Entman

(1998a)

Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.

Circulation 98:699–710

26.

Frangogiannis

Lindsey

Michael

Youker

Bressler

Mendoza

Spengler

Smith

Entman

(1998b)

Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.

Circulation 98:699–710

27.

Frangogiannis

Mendoza

Lewallen

Michael

Smith

Entman

(2001)

Induction and suppression of interferon-inducible protein (IP)-10 in reperfused myocardial infarcts may regulate angiogenesis.

FASEB J 15:1428–1430

28.

Frangogiannis

Mendoza

Lindsey

Ballantyne

Michael

Smith

Entman

(2000a)

IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury.

J Immunol 165:2798–2808

29.

Frangogiannis

Mendoza

Smith

Michael

Entman

(2000b)

Induction of the synthesis of the C-X-C chemokine interferon-gamma-inducible protein-10 in experimental canine endotoxemia.

Cell Tissue Res 302:365–376

30.

Frangogiannis

Michael

Entman

(2000c)

Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb).

Cardiovasc Res 48:89–100

31.

Frangogiannis

Perrard

Mendoza

Burns

Lindsey

Ballantyne

Michael

Smith

Entman

(1998c)

Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion.

Circulation 98:687–698

32.

Friedlander

Theesfeld

Sugita

Fruttiger

Thomas

Chang

Cheresh

(1996)

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.

Proc Natl Acad Sci USA 93:9764–9769

33.

Gordon

Marchand

(1990)

Lectin binding to injured corneal endothelium mimics patterns observed during development.

Histochemistry 94:455–462

34.

Hellstrom

Gerhardt

Kalen

Eriksson

Wolburg

Betsholtz

(2001)

Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis.

J Cell Biol 153:543–553

35.

Heymans

Luttun

Nuyens

Theilmeier

Creemers

Moons

Dyspersin

Cleutjens

Shipley

Angellilo

Levi

Nube

Baker

Keshet

Lupu

Herbert

Smits

Shapiro

Baes

Borgers

Collen

Daemen

Carmeliet

(1999)

Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.

Nature Med 5:1135–1142

36.

Hirschi

D'Amore

(1996)

Pericytes in the microvasculature.

Cardiovasc Res 32:687–698

37.

Hirschi

D'Amore

(1997)

Control of angiogenesis by the pericyte: molecular mechanisms and significance.

EXS 79:419–428

38.

Hirschi

Rohovsky

Beck

Smith

D'Amore

(1999)

Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact.

Circ Res 84:298–305

39.

Hsu

Raine

Fanger

(1981)

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

J Histochem Cytochem 29:577–580

40.

Lafleur

Forsyth

Atkinson

Murphy

Edwards

(2001)

Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.

Biochem Biophys Res Commun 282:463–473

41.

Lee

Jain

Arkonac

Zhang

Shaw

Kashiki

Maemura

Lee

Hollenberg

Lee

Haber

(1998)

Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines.

Circ Res 82:845–851

42.

Lee

Wolf

Escudero

Deutsch

Jamieson

Thistle-thwaite

(2000)

Early expression of angiogenesis factors in acute myocardial ischemia and infarction.

N Engl J Med 342:626–633

43.

Brown

Hibberd

Grossman

Morgan

Simons

(1996)

VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.

Am J Physiol 270:H1803–1811

44.

Liekens

De Clercq

Neyts

(2001)

Angiogenesis: regulators and clinical applications.

Biochem Pharmacol 61:253–270

45.

Lis

Sharon

(1986)

Lectins as molecules and as tools.

Annu Rev Biochem 55:35–67

46.

Millauer

Wizigmann-Voos

Schnurch

Martinez

Moller

Risau

Ullrich

(1993)

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Cell 72:835–846

47.

Orgad

Alroy

Ucci

Merk

(1984)

Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyper-plastic, and neoplastic canine prostate.

Lab Invest 50:294–302

48.

Paku

Paweletz

(1991)

First steps of tumor-related angiogenesis.

Lab Invest 65:334–346

49.

Pettersson

Nagy

Brown

Sundberg

Morgan

Jungles

Carter

Krieger

Manseau

Harvey

Eckelhoefer

Feng

Dvorak

Mulligan

Dvorak

(2000)

Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor.

Lab Invest 80:99–115

50.

Rongish

Torry

Tomanek

(1995)

Coronary neovascularization of embryonic rat hearts cultured in oculo is independent of thyroid hormones.

Am J Physiol 268:H811–816

51.

Rosenstein

Mani

Silverman

Krum

(1998)

Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo.

Proc Natl Acad Sci USA 95:7086–7091

52.

Shih

(1999)

The role of CD146 (Mel-CAM) in biology and pathology.

J Pathol 189:4–11

53.

St Croix

Rago

Velculescu

Traverso

Romans

Montgomery

Lal

Riggins

Lengauer

Vogelstein

Kinzler

(2000)

Genes expressed in human tumor endothelium.

Science 289:1197–1202

54.

Tonnesen

Feng

Clark

(2000)

Angiogenesis in wound healing.

J Invest Dermatol Symp Proc 5:40–46

55.

Veikkola

Alitalo

(1999)

VEGFs, receptors and angiogenesis.

Semin Cancer Biol 9:211–220

56.

Willems

Havenith

De Mey

Daemen

(1994)

The alpha-smooth muscle actin-positive cells in healing human myocardial scars.

Am J Pathol 145:868–875

57.

Yang

Graham

Kahn

Schwartz

Gerritsen

(1999)

Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels.

Am J Pathol 155:887–895

Morphological Characteristics of the Microvasculature in Healing Myocardial Infarcts

Abstract

Keywords

Materials and Methods

Ischemia/reperfusion Protocols

Immunohistochemistry

Lectin Histochemistry

Quantitative Analysis and Statistics

Results

Morphological Characteristics of Infarct Microvessels

Pericyte Coating During Maturation of Myocardial Scars

Infarct Neovessels Express CD31 and CD146 but Show Weak Staining with GS-I Histochemistry

Discussion

Structural Properties of the Infarct Microvasculature

Endothelial Cells in the Early Healing Phase Express CD31 and CD146 but Do Not Show GS-I Lectin Staining

Conclusions

Footnotes

Acknowledgements

References